Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Tamoxifen

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT01618643Completed

Aceto-whitening in the Assessment of Gastrointestinal Neoplasia

NCT02089386Early Phase 1TerminatedPrimary

Tamoxifen to Treat Barrett's Metaplasia

Showing all 2 trials

Research Network

Common Treatments

  • Tamoxifen1
  • Endoscopy1
  • Acetic Acid Chromoendoscopy1

Active Sponsors

  • University of Portsmouth1
  • Portsmouth Hospitals NHS Trust1
  • Washington University School of Medicine1

Top Investigators

Related Conditions

  • Barrett Oesophagitis With Dysplasia1
  • Barrett Esophagus1
  • Barrett Adenocarcinoma1

Activity Timeline